Last reviewed · How we verify

Ropivacaine infiltration — Competitive Intelligence Brief

Ropivacaine infiltration (Ropivacaine infiltration) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia.

phase 3 Local anesthetic (amide) Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Ropivacaine infiltration (Ropivacaine infiltration) — University Hospital, Lille. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ropivacaine infiltration TARGET Ropivacaine infiltration University Hospital, Lille phase 3 Local anesthetic (amide) Voltage-gated sodium channels
carbamazepine oxcarbazepine carbamazepine oxcarbazepine Odense University Hospital marketed Anticonvulsant / Antiepileptic agent Voltage-gated sodium channels
levobupivacaine bolus dosing levobupivacaine bolus dosing Kuopio University Hospital marketed Local anesthetic (amide) Voltage-gated sodium channels
Topical anesthetic Topical anesthetic University of Campinas, Brazil marketed Local anesthetic Voltage-gated sodium channels
Paroxetine+Lamotrigine Paroxetine+Lamotrigine Ministry of Health & Welfare, Korea marketed SSRI + anticonvulsant mood stabilizer combination Serotonin transporter (SERT); voltage-gated sodium channels; glutamate release modulation
Dose of prilocaine Dose of prilocaine Hospital General Universitario Gregorio Marañon marketed Local anesthetic (amide class) Voltage-gated sodium channels
Lower Bupivacaine Concentration Lower Bupivacaine Concentration University of Chile marketed Local anesthetic Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

  1. Poznan University of Medical Sciences · 4 drugs in this class
  2. Nantes University Hospital · 3 drugs in this class
  3. Bozyaka Training and Research Hospital · 2 drugs in this class
  4. ASST Gaetano Pini-CTO · 2 drugs in this class
  5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
  6. Chiang Mai University · 1 drug in this class
  7. Beijing Tiantan Hospital · 1 drug in this class
  8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
  9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
  10. China Medical University, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ropivacaine infiltration — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-infiltration. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: